Literature DB >> 9260216

Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child.

A P Oranje1, J F Stalder, A Taïeb, C Tasset, M de Longueville.   

Abstract

The ETAC (Early Treatment of the Atopic Child) study, a multi-national double-blind placebo-controlled randomized trials, has been in progress since 1994. Fifty-six centers in Europe and Canada participate in this study. A total of 817 children with atopic dermatitis [AD] were recruited. The severity of AD was scored using the SCORAD (objective criteria). Ninety-eight investigators (mostly pediatricians) were trained by three members of the European Task Force on Atopic Dermatitis [ETFAD] to standardize their objective SCORAD scoring (system developed by the ETFAD). The experts selected photographs and prepared a training atlas. The percentages of photographs assessed by the 98 non-expert investigators below, within and above the range of evaluations by the three experts were calculated. Taking over and underscoring together, edema/papulation was the easiest intensity item to score (82% within the range by the experts). The global symptom score, as well as lichenification, edema/papulation, oozing and excoriation registered by physicians with dermatological experience were not statistically significantly different from those by other. Erythema was statistically significantly better scored by those with dermatological experience. The results of the Euclidean Distance method showed that the item excoriations gave the largest distance. Erythema and excoriations were scored better by dermatologically experienced physicians (t-test, p = 0.042 and p = 0.063 respectively), but lichenification was better scored by non-dermatologically experienced physicians (p = 0.013). The extent of surface area involved in the disease was calculated on 3 sets of photographs. Most evaluations by the 98 nonexpert investigators were within the range of the experts. Dermatologically experienced physicians scored significantly better than the others (t-test, p = 0.006). This training program is useful for standardizing the scoring in AD and indicates that SCORAD can be used by investigators from different disciplines.

Entities:  

Mesh:

Year:  1997        PMID: 9260216     DOI: 10.1111/j.1399-3038.1997.tb00139.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  13 in total

1.  Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.

Authors:  J S Kirby; M Butt; T King
Journal:  Br J Dermatol       Date:  2019-08-27       Impact factor: 9.302

2.  Specificity in the association of anxiety, depression, and atopic disorders in a community sample of adolescents.

Authors:  Marcia J Slattery; Marilyn J Essex
Journal:  J Psychiatr Res       Date:  2010-11-25       Impact factor: 4.791

Review 3.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

Review 4.  Food allergy in Africa: myth or reality?

Authors:  Shiang-Ju Kung; Andrew P Steenhoff; Claudia Gray
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

Review 5.  Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.

Authors:  Balvinder Rehal; April W Armstrong; April Armstrong
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

Review 6.  The Traditional Chinese Medicine and Relevant Treatment for the Efficacy and Safety of Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Zhao-Feng Shi; Tie-Bing Song; Juan Xie; Yi-Quan Yan; Yong-Ping Du
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-21       Impact factor: 2.629

7.  Nutrient intake and food restriction in children with atopic dermatitis.

Authors:  Hyunjin Lim; Kyunghee Song; Ran Kim; Jiyeon Sim; Eunah Park; Kangmo Ahn; Jihyun Kim; Youngshin Han
Journal:  Clin Nutr Res       Date:  2013-01-29

8.  The Cutaneous Lupus Erythematosus Disease Activity and Severity Index: expansion for rheumatology and dermatology.

Authors:  M S Krathen; J Dunham; E Gaines; J Junkins-Hopkins; E Kim; S L Kolasinski; C Kovarik; J Kwan-Morley; J Okawa; K Propert; N Rogers; M Rose; P Thomas; A B Troxel; A Van Voorhees; J Von Feldt; A L Weber; V P Werth
Journal:  Arthritis Rheum       Date:  2008-03-15

9.  Atopic Dermatitis in Adults and Irritable Bowel Syndrome: A Cross-sectional Study.

Authors:  Z Gizem Kaya İslamoğlu; Mehmet Unal; Adem Küçük
Journal:  Indian J Dermatol       Date:  2019 Sep-Oct       Impact factor: 1.494

10.  Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Authors:  Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2021-08-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.